Effexor and Tazidime drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Effexor (venlafaxine hydrochloride) and Tazidime (ceftazidime). Common drug interactions include axillary mass among females and hepatosplenic candidiasis among males.

The phase IV clinical study analyzes what interactions people have when they take Effexor and Tazidime. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Effexor?

Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 99,493 Effexor users. Check the latest studies of Effexor.

What is Tazidime?

Tazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,409 Tazidime users. Check the latest studies of Tazidime.



On Jul, 11, 2026

24 people who take Effexor and Tazidime together, and have interactions are studied.

Effexor and Tazidime drug interactions.

What are the common drug interactions of Effexor and Tazidime, by gender? *:

female:

  1. Axillary mass
  2. Back pain
  3. Balance disorder
  4. Bladder dilatation
  5. Blood cholesterol increased
  6. Blood creatinine increased
  7. Blood glucose increased
  8. Blood pressure decreased
  9. Bone fragmentation
  10. Bone loss

male:

  1. Hepatosplenic candidiasis (fungal infection in liver and spleen)
  2. Renal failure (kidney dysfunction)
  3. Joint contracture (a permanent shortening of a muscle or joint)
  4. Joint range of motion decreased (disease of joint movement)
  5. Mobility decreased (ability to move is reduced)
  6. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  7. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  8. Oedema (fluid collection in tissue)
  9. Oedema peripheral (superficial swelling)
  10. Pain

What are the common drug interactions of Effexor and Tazidime, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Nausea (feeling of having an urge to vomit)
  2. Vomiting
  3. Cerebrospinal fluid leakage
  4. Chest pain
  5. Fatigue (feeling of tiredness)
  6. Fistula (an abnormal connection or passageway between two)
  7. Headache (pain in head)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Insomnia (sleeplessness)
  10. Localised infection (infection at the single location)

40-49:

  1. Constipation
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Cough
  4. Cyst (a closed sac)
  5. Deafness
  6. Death
  7. Decreased interest
  8. Deformity (disfigurement)
  9. Dental caries
  10. Device occlusion

50-59:

  1. Arthralgia (joint pain)
  2. Deformity (disfigurement)
  3. Erythema (redness of the skin)
  4. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  5. Gait disturbance
  6. General physical health deterioration (weak health status)
  7. Hyperkeratosis (thickening of the outer layer of the skin)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Joint contracture (a permanent shortening of a muscle or joint)
  10. Joint range of motion decreased (disease of joint movement)

60+:

  1. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  2. Respiratory distress (difficulty in breathing)
  3. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  4. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  5. Dizziness
  6. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  7. Inappropriate adh secretion
  8. Rash

What are the existing conditions these people have? *

  1. Pain: 7 people, 29.17%
  2. Stress And Anxiety: 6 people, 25.00%
  3. Fever: 4 people, 16.67%
  4. Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 4 people, 16.67%
  5. Nuclear Magnetic Resonance Imaging Brain: 3 people, 12.50%
  6. Drowsiness: 3 people, 12.50%
  7. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 8.33%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 8.33%
  9. Humoral Immune Defect (impairment of humoral immunity): 2 people, 8.33%
  10. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Effexor and Tazidime?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Effexor and Tazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Effexor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Effexor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tazidime and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on venlafaxine hydrochloride and ceftazidime (the active ingredients of Effexor and Tazidime, respectively), and Effexor and Tazidime (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: